These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 10071597

  • 1. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD, Sledge GW.
    Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
    Costa SD, von Minckwitz G, Raab G, Blohmer JU, Dresel V, Eidtmann H, Hilfrich J, Jackisch C, Merkle E, Gademann G, Kaufmann M.
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
    [Abstract] [Full Text] [Related]

  • 8. The current status of docetaxel for metastatic breast cancer.
    Esteva FJ.
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):17-26. PubMed ID: 12108894
    [Abstract] [Full Text] [Related]

  • 9. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA.
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction between Herceptin and taxanes.
    Diéras V, Beuzeboc P, Laurence V, Pierga JY, Pouillart P.
    Oncology; 2001 Apr; 61 Suppl 2():43-9. PubMed ID: 11694787
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Docetaxel: a review of its pharmacology and clinical activity.
    Trudeau ME.
    Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
    [Abstract] [Full Text] [Related]

  • 17. Treatment of patients resistant to anthracycline therapy.
    Ravdin PM.
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():13-6. PubMed ID: 8862704
    [Abstract] [Full Text] [Related]

  • 18. [Docetaxel hydrate for treatment of advanced breast cancers].
    Fujii H.
    Nihon Rinsho; 2000 Apr; 58 Suppl():254-8. PubMed ID: 11026003
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R.
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
    Hudis C.
    Clin Breast Cancer; 2002 Dec; 3(5):326-32. PubMed ID: 12533262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.